Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients

This early phase I is to find out how common vitamin D insufficiency is among African American patients with a history of prostate cancer that has not spread to other parts of the body (localized) or has spread to other places in the body (metastatic) and how vitamin D insufficiency affects the immune system. This study also aims to find out if replacing vitamin D results in normalization of the immune function. Information from this study may benefit prostate cancer patients by identifying vitamin D insufficiency which in several studies had been found to contribute to more aggressive prostat

Trial Details

NCT ID

NCT05045066

Phase

EARLY_PHASE1

Sponsor

Mayo Clinic

Status

RECRUITING

Cancer Type

Prostate Cancer

Interventions

Cholecalciferol
Quality-of-Life Assessment
Biospecimen Collection

Locations (sample)

Scottsdale, Arizona, United States|33.50921,-111.89903
Jacksonville, Florida, United States|30.33218,-81.65565

Key Eligibility Criteria

Pre-Registration:
African American males, age \>= 18 years
Patients with a previous history of localized or metastatic or locally recurrent prostate cancer
Registration:

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →